Table 2

Summary of pooled diagnostic accuracy indices

VariablesNo. studiesSensitivity (95% CI)Specificity (95% CI)Likelihood ratio+Likelihood ratio−AUROC (95% CI)I2 (95% CI)Diagnostic OR (95% CI)Meta-regression p valueEgger's test p value
Overall10 12–1990.71 (0.63 to 0.78)0.72 (0.61 to 0.81)2.57 (1.86 to 3.55)0.40 (0.32 to 0.50)0.77 (0.73 to 0.81)14.6 (0 to 56.6)5.91 (4.07 to 8.59)0.566
Follow-up time <6 months10 14 16 1940.73 (0.56 to 0.85)0.71 (0.54 to 0.83)2.50 (1.67 to 3.77)0.38 (0.24 to 0.59)0.78 (0.74 to 0.82)0.0 (0.0 to 74.6)6.34 (3.70 to 10.85)0.7590.345
Follow-up time >1 year12–14 17 1850.77 (0.69 to 0.84)0.65 (0.45 to 0.80)2.22 (3.14 to 12.88)0.35 (0.26 to 0.48)0.79 (0.75 to 0.82)34.8 (0.0 to 77.2)5.54 (3.29 to 9.32)0.5520.583
Electric cardioversion10 12 14–16 18 1970.72 (0.62 to 0.80)0.74 (0.60 to 0.85)2.81 (1.79 to 4.41)0.38 (0.29 to 0.50)0.78 (0.75 to 0.82)33.0 (0.0 to 71.6)5.13 (3.63 to 7.25)0.6110.198
Persistent AF10 12 14–16 18 1970.70 (0.61 to 0.78)0.71 (0.59 to 0.80)2.40 (1.77 to 3.25)0.42 (0.33 to 0.53)0.76 (0.72 to 0.80)22.3 (0.0 to 64.2)5.70 (3.77 to 8.62)0.8990.464
  • AF, atrial fibrillation; AUROC, area under receiver operating characteristic curve.